Summary Interleukin 3 (IL-3) is produced constituitively by WEHI-3b leukaemic cells and stimulated lymphoid cell populations in vitro. We have investigated the in vivo production of IL-3 in mice rendered leukaemic with WEHI-3b cells and mice stimulated by acute graft versus host disease (GVHD). In leukaemic mice, IL-3 was not found in serum or sonicates of 18-day spleens or bone marrow, although cells from the leukaemic organs were fully competent to elaborate IL-3 in vitro. Further, elaboration of IL-3 by WEHI cells in vitro was not affected by co-culture with normal haemopoietic cells. However, intracellular IL-3 was detected in leukaemic nodules isolated from the liver. Inhibitors specific for IL-3 were not found, although liver-cell conditioned medium and leukaemic nodule sonicates contained potent non-specific inhibitors of cell growth. At 21 days, intracellular IL-3 was also present in spleens and correlated with the presence of nonspecific inhibitors. In GVHD, no evidence for IL-3 elaboration in vivo was found, nor did lymphoid populations affected by GVHD spontaneously elaborate it in vitro; however, their competence to produce it was unaffected, as IL-3 was elaborated on subsequent mitogen stimulation in vitro.
The myelomonocyte leukaemic cell line WEHI-3b (Warner et al., 1969) is unusual in that it elaborates constituitively a number of biologically active factors such as mast-cell growth factor, megakaryocytic progenitor cell stimulator, granulocyte/macrophage stimulating factor and erythroid burst promoting activity, (but not Interleukin 2) (Metcalf, 1981; Yung & Moore, 1982; Iscove et al., 1982; Larsson et al., 1980) . Recently, we have reported the establishment in vitro of a number of murine cell lines termed Factor-Dependent Cell Lines (Paterson) (FDCP) whose growth depends absolutely on a factor [haemopoietic cell growth factor (HCGF)] contained in media conditioned by the growth of WEHI-3b cells (WEHI-3bCM) (Dexter et al., 1980) . It is also found in supernates from poke-weed mitogen-stimulated spleen cells, where it requires the presence of T cells for its elaboration (Garland & Dexter, 1982a) . The cell lines appear to be myeloid since they exhibit myeloid morphology and Correspondence: J.M. Garland
Received 27 January 1983; accepted 14 April 1983. cytochemistry, and express surface Mac-I and F4.80 antigens (Garland & Dexter, 1982b; Garland et al., 1982) ; antigenically, they bear resemblance to WEHI-3b cells. Somewhat similar cell lines have also been described by Greenberger (1980) and Hapel et al. (1981) in the latter case classified as lymphoid largely on the criteria of Thy antigen and expression of 20a steroid dehydrogenase . The factor promoting these "lymphoid" lines has been termed "Interleukin-3" (IL-3) and appears to be the same as HCGF (reviewed in ; both activities are associated with a 28-3OKd glycoprotein (Bazill et al., 1983; and purified IL-3 optimally promotes FDCP. Additionally, HCGF and IL-3 promote the proliferation of multipotential stem cells, (Bazill et al., 1983; Garland & Crompton, 1983) and basophil/mast cells in vitro (Schrader et al., 1981 ; J. Ihle, personal communication) . The existence of FDCP thus provides a ready and sensitive assay for The phenotypic similarity of IL-3 requiring FDCP to the IL-3 producing leukaemic WEHI-3b line raised the intriguing possibility that they were related, the leukaemic state being associated with the endogenous, constituitive production of a growth factor operative on a number of haemopoietic cell lineages in vitro. For this to be true, it would be necessary to show that IL-3 was made in vivo and existed in measurable amounts particularly in the cytoplasm of leukaemic cells; that is, it is not an in vitro artifact. Further, it may be asked (i) is IL-3 involved in the regulation of normal cells, as its origin from stimulated lymphoid populations would suggest, and (ii) are FDCP also representative of a normal cell population?
We have tried to answer these questions by firstly seeking the activity in situations induced in vivo which parallel those in vitro where IL-3 is produced: namely during the pan-lymphocyte stimulation associated with acute graft versus host disease (GVHD)-a parallel of mitogen stimulation (Ford et al., 1981) ; and in mice rendered acutely leukaemic after transfusion with WEHI-3b cells. Secondly, we have followed the fate of FDCP cells after injection into normal and irradiated mice.
Throughout this study and in the absence of any indication that factors other then IL-3 (or HCGF) promote FDCP, we have equated FDCP stimulatory activity with the presence of IL-3.
Materials and methods
Induction of WEHI-3b leukaemia and cell culture WEHI-3b cells were cultured in Fischer's medium (Gibco Biocult) supplemented with 10% horse or foetal calf serum (Gibco Biocult). For leukaemia induction, syngeneic Balb/C mice were injected i.v. with 105, 106 or 107 washed WEHI-3b cells. The mice were inspected daily and when showing signs of leukaemia were killed and the serum collected. Suspensions of the spleen cells were made by teasing, and of the bone marrow by aspirating the femoral cavity with a syringe. Resulting suspensions were cultured at 104 cells ml-1 in RPMI 1640 (Gibco Biocult)/10% FCS for 3 days at 370 in 5% CO2. Leukaemic nodules in the liver were dissected out individually, and weighed before teasing and sonication. Representative livers were also fixed in Bouin's solution for leukaemic nodule estimations.
Induction of GVHD
Parental strain spleen cells (106) from C57B1/6 mice were injected i.v. into B6D2F1 recipients. At various intervals, a number of mice (6 per group) were sacrificed. After collecting and pooling the serum, the spleens were weighed and a small fragment fixed in glutaraldehyde for sectioning. Three of the remaining spleens were dissociated and a single cell suspension was made. After red-cell lysis in hypotonic conditions, 106 cells ml-1 were cultured in RPMI/10% FCS with and without 1% Poke-weed mitogen (Gibco Biocult) at 370 in 5% CO2 for 3 days.
Assay for The factor dependent lines FDCP-7,-2, and Al. For viability assays, an equal volume of Trypan Blue solution (0.5% in saline) was added to an aliquot of cell suspension, and the proportion of dead cells counted.
Preparation of assay samples and cell sonicates Cell supernates were assayed after centrifugation at 3000 rpm to remove cells followed by 0.22 p millipore filtration. Sonicates were prepared by lysing 5 x 106 to I07 washed nucleated cells mlP-on ice using 20 second bursts of ultrasound (MSE ultrasonicator 6-12 p peak height). All sonicates were checked for breakage, the debris spun out at 20,000 rpm (30,000 g) for 1 h and then sterilised by Half-life of IL-3 activity in vivo A preparation of partially-purified factor with very high IL-3 activity was kindly provided by Dr. G. Bazill (Bazill et al., 1983 ). An amount equivalent to approximately 10ml WEHI-3b CM (active at 10%) was injected i.v. into a number of normal mice from which serum was collected at known intervals by heart puncture.
Cell lines FDCP-7 and -2 have been previously described (Dexter et al., 1980; Garland & Dexter, 1982a) . The lines A2C2 and A1.I.1.C2 are Thyl.2 negativc FDCP generated from long-term bone marrow culture (LTBMC) at 4 weeks (Garland & Dexter, 1982) . All the cell lines are promoted by IL-3 and are refractory to T cell growth factor, GM/CSF and other known cell proliferation factors (Garland & Dexter, 1982b) . The cell line 15al is a sub-clone of the factor-independent line 416B, also derived from LTBMC (Dexter et al., 1979) .
Fractionation of IL-3 activity on Biogel P30 Samples (0.2 ml) were fractionated on a 28 x 1.2cm diameter Biogel P30 (Biorad Labs Ltd) polyacrylamide column equilibrated in PBS (0.85% NaCl; 0.01 M phosphate) and run at 2 ml hr-at room temperature. Fractions of 0.32 ml were collected and assayed at a final concentration of 25%. Results IL-3 activity in the mice undergoing acute G VHD Mice were sampled at various times after GVHD induction. No activity was found in the serum at any stage, and titration of pooled GVHD serum showed no significant inhibition of IL-3 responses at levels below 20% serum (see below). Spleen cells were then cultured with and without PWM, and the supernates tested for IL-3 (Table I) . No activity was found when the cells were cultured alone, but at all stages of GVHD, as indicated by spleen index, high concentrations of IL-3 were induced by PWM in vitro which titrated down to 5% CM or less. Thus, the cells were still competent to make it. Histology of the spleens at these time-points showed pathologies consistent with moderate to severe GVHD reactions. (Table II) . The relative absence of normal progenitors responding to G/M CSF in leukaemic organs was explicable on their dilution by leukaemia cells, although they were still present (Table II, 105 injected WEHI-3b cells). Thirty individual agar colonies were picked at random from leukaemic spleens and sub-cultured. All clones grew spontaneously and made IL-3. Three cultures were karyotyped and had karyotypes of WEHI-3b (Table III) . This could be due to inhibitors present in the serum. However, titration curves showed that neither normal nor leukaemic serum significantly inhibited the responses of FDCP to IL-3 (Figure 1 ) below 10% leukaemic serum concentration in the presence of optimal IL-3 concentrations. Nor was inhibition seen at suboptimal levels of IL-3 (2.5%). Thus, failure to detect IL-3 in leukaemic serum was not due to the presence of overt inhibitors. aSerum was used at 5% final concentration (see Figure   1 ). (Table V) . Further, normal spleen and marrow cells did not inhibit the production of, or markedly absorb, IL-3 in vitro as shown in Table VI ; very high concentrations of normal spleen and marrow cells were co-cultured with WEHI-3b cells without producing a significant drop in IL-3 titre, particularly during the early synthetic phase when inhibition or absorption would have greatest effect. It was therefore important to determine if this apparent lack of IL-3 synthesis in vivo was common to all leukaemic cells regardless of anatomical site. Sonicates of leukaemic nodules from the livers at 18 days contained significant IL-3 activity but it was masked at high sonicate concentrations by inhibitors (Table IV) . The level of activity in sonicates was approximately 5-fold less than that in a similar quantity of WEHI-3b cells grown in vitro. Thus, liver nodule sonicates contrasted with those from leukaemic marrow and spleen in the presence of both IL-3 and inhibitors. Having demonstrated production in vivo of IL-3 within compact WEHI3b colonies, mice were taken to 21 days and spleen and marrow sonicates examined for IL-3 (Table  VII) . In contrast to the previous results, IL-3 activity was now detectable in spleen sonicates, but the levels were low (more than 10-fold lower than in in vitro sonicates) and there was indication of the presence of inhibitors. To determine whether the inhibition was specific to IL-3 dependent cells, the same sonicates were titrated against the factorindependent haemopoietic cell line 416B. The results showed that the inhibition was not specific as the factor-independent line was also inhibited (Table VII) . Visual examination of the wells showed that the [3H]dT incorporation reflected cell viability and proliferation and not competition for isotope by small molecular weight nucleotides released during sonication. Day 3 assay samples showed levels of IL-3 activity equal to 10% standard WEHI-3b CM in cell supernates (S-N). Molecular weight fractionation of in vivo IL-3 It was possible that in vivo IL-3 activity was associated with a molecular species different from in vitro IL-3. Liver nodule sonicates were therefore fractionated on Biogel P30, the elution pattern being compared with that of WEHI-3b CM and a preparation IL-3. IL-3 eluted with an apparent average mol.wt of 28Kd, (Figure 3 ) but recovery was low; -80% was irreversibly bound (2 experiments). However, a similar mol. wt average for IL-3 has recently been given . In common with previous experience (Bazill et al., 1983 ) WEHI-3b CM eluted over a broader slightly higher mol. wt range with an average of 32 Kd (mean peak height). Liver sonicate activity eluted almost identically to IL-3 (with an enhanced shoulder at 32Kd). The elution characteristics of the in vivo activity therefore were closely similar to IL-3 and WEHI-3b CM. Figure 4) ; these showed a rapid traffic of label between spleen and lungs over the first 8h. Only small numbers of cells (<2%) were found in the marrow, and virtually none in thymus. Most cells apparently lodged in the liver eventually (at -12 h). The circulation of FDCP, was, however, quite different ( Figure 5 ). There was progressive re-circulation from the lungs to both spleen and liver; this continued over a period of nearly 20h, and was not complete until after this time. Approximately the same number of FDCP lodged in the marrow, gut and thymus as normal marrow cells. Similar results were recorded in lethally-irradiated recipients (data not shown). Thus, although no FDCP were recovered in the previous experiments the cells were still recirculating in vivo.
Tube no. Note progressive accumulation of counts in liver and spleen and reciprocal loss from lungs.
FDCP: 2000 liver cells, colony formation was completely inhibited, (Table VIII) although at lower ratios (1: 400) colonies were observed. In WEHI-3b CM supplemented liquid culture, FDCP apparently survived for at least 2 days as judged by phase microscopy when co-cultured with ratios of 1:1000 and 1: 5000 liver cells, but despite repeated subculturing, none were subsequently recovered. These results could be due to absorption of the IL-3 by liver cells. Initial results using unseparated liver suspensions to absorb WEHI-3b CM suggested that IL-3 activity was very rapidly lost (none at 4 h incubation). Experiments were therefore performed using liver suspensions separated by centrifugation into a cell-free supernate and two sizes of pellet. These were used to absorb excess and sub-optimal amounts of IL-3, the supernates being titrated against both an FDCP line and a factor-independent line, 15 al. Titrations of the absorbed supernates showed that by both [3H]dT assay and viability estimation, considerable inhibitory activity on both the FDCP line and 15 al factor-independent line was present in all samples after 2 h incubation particularly in the 100,000 g supernate. However, the IL-3 activity was unchanged and re-appeared at higher dilutions of supernates (Table IX) . As the viability of the initial liver cells suspensions was low (15-20%), these results show that in vitro neither liver cells nor their released contents contain degradative enzymes or inhibitors specific to IL-3 and the inhibition of FDCP cells in vitro previously found with liver cells was probably due to non-specific toxicity.
Response of WEHI-3b cells to IL-3 If WEHI-3b cells respond to extracellular IL-3, we reasoned that actively-growing cells replaced in fresh medium may suffer an extended early lag period whilst sufficient IL-3 accumulates to restimulate growth. We therefore compared cells replaced in fresh medium with those in 50% of their own conditioned medium, Figure 6 . However, this showed that there was no difference in the early proliferative responses of cells with or without added IL-3; the two curves were parallel and almost superimposed. Over the first few hours of re-culture, proliferation in both cultures decreased bOriginal in the conditioned media; concentration was 12, 6 and 3% respectively in the assay. significantly; after 24 h in fresh medium proliferation had increased, and logarithmic growth started; but cells replaced in the conditioned medium were still depressed. Viability in both cultures paralleled the thymidine uptake, but the effect was much less; the maximum drop was not more than 25% at 2 h (data not shown).
Discussion
The purpose of these studies was to determine the presence of IL-3 in vivo and the fate of IL-3 dependent cell lines. Parallels exist for other haemopoietic growth factors, for example, G/M CSF and TCGF. CSF is elaborated in vivo, as it is readily obtained frqm sources such as urine and serum (Moore et al., 1974; Das et al., 1981; Burgess & Metcalf, 1980) , although injected CSF has a short life (Shadduck et al., 1980) . Additionally, radiolabelled CSF has some affinity for the haemopoietic tissue on which it acts (Shadduck et al., 1980) . In terms of target cells, CSF promotes both proliferation and differentiation of myeloid progenitors (Burgess & Metcalf, 1980) such that functional cells are produced in vitro (Gorczynski et al., 1980) . Likewise, activated T-cells have receptors for IL-2, which appears to be a proliferation-mediator without differentiating ability (Raulet & Bevan, 1982) . Although much is now known about cellular mechanisms related to IL-2 promoted proliferation in vitro (Maizel et al., 1981; Sekaly et al., 1982) , its production in vivo is still uncertain; this may be related again to its short half-life in vivo and the presence of inhibitors in serum (Wagner et al., 1980; Bindon et al., 1982) . However, injection of IL-2 into immunodeficient animals (nu/nu mice) appears to result in establishment of T-cell like responses suggesting that it may act physiologically (Wagner et al., 1980) ; a similar conclusion has been made for the myeloid differentiation factor described by Lotem & Sachs (1981) . Our experiments are different in that we have used a constituitive (in vivo) lymphokine-producing leukaemic cell line. We found intracellular lymphokine in early leukaemic liver nodules, and have shown that it is identical or very closely similar to IL-3 produced in vitro. Although we did not find it initially in corresponding marrow or spleen lysates, nor in serum, its presence intracellularly in spleens from terminal leukaemic mice suggests that the problem in earlier lysates is logistical; the amount in vivo is considerably less than in a corresponding number of cells grown in vitro. Further, the intracellular presence of IL-3 is correlated with the presence of potent inhibitors which mask its activity in vitro and suppress other cells. This may be relevant to the requirement for a minimal number of WEHI-3b cells to induce leukaemia, and the long latent period before the leukaemia becomes overt; in vitro, the mass-generation time of WEHI-3b cells is about 18 h, and at this proliferation rate a 15-day leukaemic mouse would greatly exceed its own body-weight in leukaemic cell load.
Our experiments thus show conclusively that IL-3 is not an in vitro artifact; and suggest that its production may be related to the leukaemic state. Thus, the factor (or a group of very similar ones) promotes many cell lineages in vitro (Garland & Dexter, 1982b; Bazill et al., 1983; Garland & Crompton, 1983; Iscove et al., 1982) and "immortalises" cell lines with characteristics of the WEHI-3b leukaemic line (Dexter et al., 1980) . "Misplaced" elaboration of IL-3 internally could therefore be a universal route to leukaemia induction within a range of haemopoietic cells. In WEHI-3b cells, such a mechanism does not appear to involve surface receptors, as if actively-growing WEHI-3b cells are replated in WEHI-3b CM, there is no enhancement of proliferation compared to controls without WEHI-3b CM; both cultures suffer equal falls in [3H]dT incorporation before growth is resumed. The reason for the initial fall is not clear; we have consistently observed a similar effect in FDCP replated in fresh medium with IL-3, and it appears to be related to the physical manipulation of the cells. The apparent continuing depression in the culture with conditioned medium does not seem to be entirely explicable on medium quality (50% conditioned medium) as firstly, the cells were actively growing in it at 100% and secondly, the dilution by fresh medium should have allowed at least one doubling over 18 to 20 h (maximum culture density of WEHI-3b cells is .-22x 106 cellsml ').
In contrast to le7ukaemic mice, in vitro culture of lymphocytes activated in vivo by GVH reactions is not associated with IL-3 production. This is somewhat surprising as in early GVH reactions a significant component of the proliferation is host cell (Ford et al., 1981) , presumably mediated by soluble factors in vivo (English, 1982) . With regard to the inability to recover FDCP after in vivo injection, the recirculation and co-culture experiments suggest that one major problem is nonspecific cell toxicity generated by normal cells e.g. liver, in vitro. Thus, the nuntber of normal cells needed to be harvested to ensure adequate representation of FDCP cells is more than sufficient to inhibit their growth; in addition IL-3 is rapidly cleared in vivo and FDCP are sensitive to factor withdrawal (Garland & Dexter, 1982b) . The most likely explanation is therefore that FDCP neither proliferate nor survive long enough to recover. However, there is a report of similar WEHI-3b CM dependent lines maturing in vivo in diffusion chambers . It therefore seems paradoxical that FDCP lines can be generated at all; all the lines have been derived from long-term marrow cultures, which are defective in T-cells (Phillips, 1980; Schrader et al., 1979) . Marrow cultures do not elaborate detectable levels of IL-3 but can be induced to do so if T-cells are supplied (J. Garland, in preparation) . If the lines are absolutely dependent on IL-3, then either IL-3 is elaborated at micro-levels in the cultures, in a manner similar to G/M CSF (Shadduck et al., 1980) , or FDCP represent lines that do not normally arise but are "diverted" to IL-3 dependency by culture selection. This seems unlikely as firstly, IL-3 which is very closely similar if not identical to HCGF, promotes other recognisable cell lineages in vitro (Bazill et al., 1982; Garland & Crompton, 1982) , and secondly, other cell lines dependent on added factors can function in vivo as in the case of cloned NK lines (Warner & Dennert, 1982) . Apparently, GVH mice do have increased numbers of IL-3 promoted progenitors (J. Schrader, personal communication) and studies to determine the fate of IL-3 dependent lines in WEHI-3b leukaemic mice are in progress.
Finally, although FDCP do not seem to be related to T-cells themselves, they respond to a Tcell associated factor and it is tempting to speculate that one set of T-cell functions may be to assist in the regulation of haemopoiesis, unrelated to their undoubted function in immunity. Support for the notion can be found in numerous examples of Tcell help for proliferation of CFUs and indeed the establishment of long-term haemopoietic cultures (Sharp et al., 1981; Dexter et al., 1977) .
Our conclusions are that IL-3 is not an in vitro artifact and that it may be related to the leukaemic potential of WEHI-3b cells. Problems still remain with identifying the factor as a physiological haemopoietic regulator, but the construction of genetic probes and antibodies to it offers a fruitful direction to pursue.
